← Leaderboards
Karina J Yoon
University Of Alabama At Birmingham
$2,413,128
Attributed
$2,413,128
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $499.6K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,413,128 · 3
By mechanism
R01$1,688,278 · 1
R21$724,850 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Barry P Sleckman$19,849,738
- Kejin Hu$1,554,306
- Xiaoguang Margaret Liu$3,757,363
- Frank Furnari$6,666,697
- Christopher Ryan Miller$3,962,587
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularReportingHistonesLysineRelapse PatientsProteinsClinical TrialsGenetic TranscriptionIn VitroLiteratureGemcitabineBindingEffective TherapyDrug ResistanceAffectChemotherapyCytotoxicityGene ProductComplexCharacteristicsIn VivoBromodomainDna DamageResistance
Grant awards (9)
Mechanism-based combination therapy for cholangiocarcinoma$164,881
R21 · FY2024 · CA · contact PI
Mechanism-based combination therapy for cholangiocarcinoma$208,271
R21 · FY2023 · CA · contact PI
Developing novel combination therapies for pancreatic cancer$339,694
R01 · FY2021 · CA · contact PI
Developing novel combination therapies for pancreatic cancer$339,694
R01 · FY2020 · CA · contact PI
Developing novel combination therapies for pancreatic cancer$329,502
R01 · FY2019 · CA · contact PI
Developing novel combination therapies for pancreatic cancer$339,694
R01 · FY2018 · CA · contact PI
Developing novel combination therapies for pancreatic cancer$339,694
R01 · FY2017 · CA · contact PI
Developing Therapy for the Treatment of Cholangiocarcinoma$159,863
R21 · FY2017 · CA · contact PI
Developing Therapy for the Treatment of Cholangiocarcinoma$191,835
R21 · FY2016 · CA · contact PI